Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.


Our Mission

The mission at MEI Pharma is to develop novel and differentiated cancer therapies intended to improve patient benefit. Our approach to oncology drug development is to evaluate our drug candidates in combinations with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs to provide improved patient benefit.

Financial Data

Show all

Recent Reports

SEC Filings

Our Commitment

In pursuing our mission to develop novel and differentiated cancer therapies, we are committed to doing so in a manner that serves society more broadly, including the environment, good corporate governance practices, and supporting diversity, equality and inclusion at our company and in the communities in which we serve and operate.